Molecular docking, drug-likeness and DFT study of some modified tetrahydrocurcumins as potential anticancer agents.

Publication Year: 2023

DOI:
10.1016/j.jsps.2023.101889

PMCID:
PMC10714243

PMID:
38090737

Journal Information

Full Title: Saudi Pharm J

Abbreviation: Saudi Pharm J

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Pharmacology & Pharmacy

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper."

Evidence found in paper:

"The authors acknowledge Cihan University-Erbil, Iraq and Çankırı Karatekin University, Turkey for financial support. The authors extend their appreciation to the Researchers Supporting Project number (RSPD2023R620), King Saud University, Saudi Arabia. Ahmed Mahal: Conceptualization, Supervision, Writing – original draft, Writing – review & editing. Marwan Al-Janabi: Methodology, Writing – original draft. Volkan Eyüpoğlu: Supervision, Writing – original draft. Anas Alkhouri: Formal analysis, Resources, Writing – original draft. Samir Chtita: Formal analysis, Resources, Writing – original draft. Mustafa M. Kadhim: Formal analysis, Resources. Ahmad J. Obaidullah: Formal analysis, Resources, Funding acquisition. Jawaher M. Alotaibi: Formal analysis, Resources, Funding acquisition. Xiaoyi Wei: Formal analysis, Resources. Mohammad Rizki Fadhil Pratama: Writing – original draft."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025